A retrospective analysis of early CA19-9 change in salvage chemotherapy for refractory pancreatic cancer

Author： Nakai Yousuke   Isayama Hiroyuki   Sasaki Takashi   Takahara Naminatsu   Hamada Tsuyoshi   Uchino Rie   Mizuno Suguru   Miyabayashi Koji   Yamamoto Keisuke   Mohri Dai   Kogure Hirofumi   Yamamoto Natsuyo   Hirano Kenji   Ijichi Hideaki   Tateishi Keisuke   Tada Minoru   Koike Kazuhiko  

Publisher： Springer Publishing Company

ISSN： 0344-5704

Source： Cancer Chemotherapy and Pharmacology, Vol.72, Iss.6, 2013-12, pp. : 1291-1297

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Related content

A retrospective study of S-1 and oxaliplatin combination chemotherapy in patients with refractory pancreatic cancer

By Takahara Naminatsu   Isayama Hiroyuki   Nakai Yousuke   Sasaki Takashi   Hamada Tsuyoshi   Uchino Rie   Mizuno Suguru   Miyabayashi Koji   Kogure Hirofumi   Yamamoto Natsuyo   Sasahira Naoki   Hirano Kenji   Ijichi Hideaki   Tateishi Keisuke   Tada Minoru   Koike Kazuhiko  

Cancer Chemotherapy and Pharmacology, Vol. 72, Iss. 5, 2013-11 ,pp. : 985-990

Springer Publishing Company

Access to resources Recommend Favorite

CEA and CA19.9 as Early Predictors of Progression in Advanced/Metastatic Colorectal Cancer Patients Receiving Oxaliplatin-Based Chemotherapy and Bevacizumab

By Petrioli Roberto   Licchetta Antonella   Roviello Giandomenico   Pascucci Alessandra   Francini Edoardo   Bargagli Gianluca   Conca Raffaele   Miano Salvatora Tindara   Marzocca Giuseppe   Francini Guido    

Cancer Investigation, Vol. 30, Iss. 1, 2012-01 ,pp. : 65-71

Informa Healthcare

Access to resources Recommend Favorite

Biomarkers for pancreatic cancer: promising new markers and options beyond CA 19-9

By Ballehaninna Umashankar   Chamberlain Ronald  

Tumor Biology, Vol. 34, Iss. 6, 2013-12 ,pp. : 3279-3292

Springer Publishing Company

Access to resources Recommend Favorite

Elevated levels of CA 19-9 and CEA in pancreatic cancer-associated diabetes

By Guo Qingqu   Kang Muxing   Zhang Bo   Chen Ying   Dong Xin   Wu Yulian  

Journal of Cancer Research and Clinical Oncology, Vol. 136, Iss. 11, 2010-11 ,pp. : 1627-1631

Springer Publishing Company

Access to resources Recommend Favorite

Prospective evaluation of the contribution of K-ras mutational analysis and CA 19.9 measurement to cytological diagnosis in patients with clinical suspicion of pancreatic cancer

By Urgell E.   Puig P.   Boadas J.   Capella G.   Queralto J.M.   Boluda R.   Antonijuan A.   Farre A.   Llus F.   Gonzalez-Sastre F.   Mora J.  

European Journal of Cancer, Vol. 36, Iss. 16, 2000-10 ,pp. : 2069-2075

Elsevier

Access to resources Recommend Favorite